Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | OGFOD1 | Q8N543 | 1/20 | 0.34 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.34 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | HIF1AN | Q9NWT6 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.31 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7910490 | 0.82 | MT-CO2 (0.40) | SIRT2SIRT1SRD5A1MT-CO2 | |
| SCHEMBL2558802 | 0.78 | HCAR3 (0.48) | — | |
| SCHEMBL8117544 | 0.75 | POLB (0.37) | MT-CO2 | |
| SCHEMBL8125489 | 0.74 | LMNA (0.36) | MAPK1SRD5A1 | |
| SCHEMBL1509167 | 0.74 | GAA (0.41) | CRBNTET2OGFOD1TET1EGLN2 | |
| SCHEMBL8723112 | 0.73 | KDM4E (0.34) | GPR119 | |
| SCHEMBL16938414 | 0.73 | GABRP (0.49) | CRBNMAPK1 | |
| SCHEMBL4758814 | 0.73 | HDAC1 (0.45) | MAPK1 | |
| SCHEMBL7907251 | 0.71 | NPSR1 (0.35) | GPR119MAPK1 | |
| SCHEMBL1445644 | 0.71 | MAPK1 (0.40) | CRBNMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025105948-A1 | [99MTC]TC-IPD-L1 AS A TETRADECAPEPTIDE RADIOPHARMACEUTICAL FOR DETECTING AND MONITORING THE OVEREXPRESSION OF THE PD-L1 PROTEIN | INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES (MX) | 2025-05-22 | — | — | WO | disclosed |
| CN-107382846-A | PSMA bonding agents and application thereof | 约翰.霍普金斯大学 | 2017-11-24 | — | — | CN | disclosed |
| US-RE46171-E1 | Functional biopolymer modification reagents and uses thereof | SOLULINK, INCORPORATED (US) | 2016-10-04 | — | — | US | disclosed |
| EP-2298736-B1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INC (US) | 2015-07-15 | — | — | EP | disclosed |
| EP-2295407-B1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | SOLULINK INC (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-1315699-B1 | HYDRAZINE-BASED AND CARBONYL-BASED BIFUNCTIONAL CROSSLINKING REAGENTS | SOLULINK INC (US) | 2013-01-02 | — | — | EP | disclosed |
| US-7999098-B2 | Triphosphate oligonucleotide modification reagents and uses thereof | SOLULINK BIOSCIENCES, INC. (US) | 2011-08-16 | — | — | US | disclosed |
| EP-2298736-A1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | Solulink, Inc. (US) | 2011-03-23 | — | — | EP | disclosed |
| EP-2295407-A1 | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents | Solulink, Inc. (US) | 2011-03-16 | — | — | EP | disclosed |
| US-7732628-B2 | Such as 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]benzaldehyde, 4-[8-(2-cyanoethyl-N,N-diisopropylphosphoramidyloxy)-2-aza-1-oxooct-1-yl]acetophenone; for incorporation into oligonucleotides during immobilization and conjugation of biopolymers in solid phase synthesis | SOLULINK INCORPORATED (US) | 2010-06-08 | — | — | US | disclosed |
| US-5879657-A | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1999-03-09 | — | — | US | disclosed |
| US-5753520-A | BIOCHEMICAL CONJUGATED WITH A HYDRAZINE OR A HYDRAZONE COMPOUND AS DRUG DELIVERY; HIGH BIOLOGICAL SPECIFICITY; MEDICINE FOR IMAGING, THERAPY, RADIOACTIVE TAGGING | JOHNSON MATTHEY INC. (US) | 1998-05-19 | — | — | US | disclosed |
| US-5679778-A | FOR FORMING CONJUGATES WITH MACROMOLECULES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1997-10-21 | — | — | US | disclosed |
| EP-0384769-B1 | Protein labelling | JOHNSON MATTHEY PLC (GB) | 1996-04-24 | — | — | EP | disclosed |
| EP-0667859-A1 | MOLECULE LABELLING USING 2-HYDRANINOPYRIDINE DERIVATIVES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1995-08-23 | — | — | EP | disclosed |
| US-5420285-A | Imaging for medicine | JOHNSON MATTHEY, INC. (US) | 1995-05-30 | — | — | US | disclosed |
| WO-1994022494-A1 | RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994010149-A1 | MOLECULE LABELLING USING 2-HYDRANINOPYRIDINE DERIVATIVES | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1994-05-11 | — | — | WO | disclosed |
| US-5206370-A | Certain pyridyl hydrazines and hydrazides useful for protein labeling | JOHNSON MATTHEY, INC. (US) | 1993-04-27 | — | — | US | disclosed |
| EP-0384769-A2 | Protein labelling | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 1990-08-29 | — | — | EP | disclosed |